290 related articles for article (PubMed ID: 17457780)
1. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study.
Karade SK; Kulkarni SS; Ghate MV; Patil AA; Londhe R; Salvi SP; Kadam DB; Joshi RK; Rewari BB; Gangakhedkar RR
PLoS One; 2017; 12(8):e0181889. PubMed ID: 28763465
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study.
Scriven YA; Mulinge MM; Saleri N; Luvai EA; Nyachieo A; Maina EN; Mwau M
Medicine (Baltimore); 2021 Oct; 100(40):e27460. PubMed ID: 34622871
[TBL] [Abstract][Full Text] [Related]
4. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.
Kiros M; Biset S; Gebremariam B; Yalew GT; Abegaz WE; Geteneh A
Virol J; 2023 Oct; 20(1):243. PubMed ID: 37880705
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV Drug Resistance Mutations among Treatment-Naive People Living with HIV in a Tertiary Care Center in India.
Srivastva S; Chakravarty J; Kushwaha AK
Am J Trop Med Hyg; 2024 Apr; 110(4):713-718. PubMed ID: 38442417
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral resistance among HIV-1 patients on first-line therapy attending a comprehensive care clinic in Kenyatta National Hospital, Kenya: a retrospective analysis.
Kinyua JG; Lihana RW; Kiptoo M; Muasya T; Odera I; Muiruri P; Songok EM
Pan Afr Med J; 2018; 29():186. PubMed ID: 30061964
[TBL] [Abstract][Full Text] [Related]
7. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States.
Mukerji SS; Misra V; Lorenz DR; Uno H; Morgello S; Franklin D; Ellis RJ; Letendre S; Gabuzda D
Clin Infect Dis; 2018 Sep; 67(8):1182-1190. PubMed ID: 29617912
[TBL] [Abstract][Full Text] [Related]
8. Human Immunodeficiency Virus-1 Drug Resistance Mutations in Iranian Treatment-experienced Individuals.
Bokharaei-Salim F; Khanaliha K; Monavari SH; Kiani SJ; Tavakoli A; Jafari E; Chavoshpour S; Razizadeh MH; Kalantari S
Curr HIV Res; 2024; 22(1):53-64. PubMed ID: 38310469
[TBL] [Abstract][Full Text] [Related]
9. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Viñuela L; de Salazar A; Fuentes A; Serrano-Conde E; Falces-Romero I; Pinto A; Portilla I; Masiá M; Peraire J; Gómez-Sirvent JL; Sanchiz M; Iborra A; Baza B; Aguilera A; Olalla J; Espinosa N; Iribarren JA; Martínez-Velasco M; Imaz A; Montero M; Rivero M; Suarez-García I; Maciá MD; Galán JC; Perez-Elias MJ; García-Fraile LJ; Moreno C; Garcia F
J Med Virol; 2023 Dec; 95(12):e29287. PubMed ID: 38084763
[TBL] [Abstract][Full Text] [Related]
10. High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
de Mulder M; Yebra G; Navas A; de José MI; Gurbindo MD; González-Tomé MI; Mellado MJ; Saavedra-Lozano J; Muñoz-Fernández MÁ; de Ory SJ; Ramos JT; Holguín A;
PLoS One; 2012; 7(12):e52155. PubMed ID: 23284913
[TBL] [Abstract][Full Text] [Related]
11. Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia.
Mulu A; Lange T; Liebert UG; Maier M
BMC Infect Dis; 2014 Mar; 14():158. PubMed ID: 24655349
[TBL] [Abstract][Full Text] [Related]
12. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.
Theys K; Deforche K; Vercauteren J; Libin P; van de Vijver DA; Albert J; Asjö B; Balotta C; Bruckova M; Camacho RJ; Clotet B; Coughlan S; Grossman Z; Hamouda O; Horban A; Korn K; Kostrikis LG; Kücherer C; Nielsen C; Paraskevis D; Poljak M; Puchhammer-Stockl E; Riva C; Ruiz L; Liitsola K; Schmit JC; Schuurman R; Sönnerborg A; Stanekova D; Stanojevic M; Struck D; Van Laethem K; Wensing AM; Boucher CA; Vandamme AM;
Retrovirology; 2012 Oct; 9():81. PubMed ID: 23031662
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy.
Kemp SA; Charles OJ; Derache A; Smidt W; Martin DP; Iwuji C; Adamson J; Govender K; de Oliveira T; Dabis F; Pillay D; Goldstein RA; Gupta RK
mBio; 2022 Jun; 13(3):e0026922. PubMed ID: 35446121
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.
Bartmeyer B; Kuecherer C; Houareau C; Werning J; Keeren K; Somogyi S; Kollan C; Jessen H; Dupke S; Hamouda O;
PLoS One; 2010 Oct; 5(10):e12718. PubMed ID: 20949104
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Assessment of Virological Failure and Antiretroviral Drug Resistance among Treatment-naive Subjects Living with HIV.
Mendes Marcon CE; Schlindwein AD; Schuelter-Trevisol F
Curr HIV Res; 2023; 21(3):213-219. PubMed ID: 37226784
[TBL] [Abstract][Full Text] [Related]
16. Biological parameters determining the effectiveness of monitoring of HIV / AIDS infected patients in Morocco.
Echchakery M; Boumezzough A; Boussaa S
Afr Health Sci; 2023 Jun; 23(2):109-120. PubMed ID: 38223572
[TBL] [Abstract][Full Text] [Related]
17. Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.
Fiebig U; Altmann B; Hauser A; Koppe U; Hanke K; Gunsenheimer-Bartmeyer B; Bremer V; Baumgarten A; Bannert N
BMC Infect Dis; 2023 Oct; 23(1):673. PubMed ID: 37817087
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State.
Karchava M; Pulver W; Smith L; Philpott S; Sullivan TJ; Wethers J; Parker MM
J Acquir Immune Defic Syndr; 2006 Aug; 42(5):614-9. PubMed ID: 16868498
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 drug resistance in treatment-naive chronically infected patients in Jamaica.
Barrow GJ; Hylton-Kong T; Rodriguez N; Yamamura Y; Figueroa JP
Antivir Ther; 2013; 18(7):941-4. PubMed ID: 23744572
[TBL] [Abstract][Full Text] [Related]
20. Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study.
; Dolling D; Sabin C; Delpech V; Smit E; Pozniak A; Asboe D; Brown AL; Churchill D; Williams I; Geretti AM; Phillips A; Mackie N; Murphy G; Castro H; Pillay D; Cane P; Dunn D; Dolling D
BMJ; 2012 Aug; 345():e5253. PubMed ID: 22915687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
